2021 Best In KLAS Cardiology Hemodynamics

Perception

Optum/Change Healthcare Merger

16 August 22 | Boyd Stewart and Sam Eaquinto

In January 2021, Optum announced their intentions to acquire Change Healthcare. The merger remains unfinalized, however, as the US Department of Justice blocked the deal in February 2022 due to anticompetition concerns—such a merger would give UnitedHealth Group, Optum’s parent company and the nation’s largest insurer, access to rivals’ sensitive data. The legal proceeding is ongoing and scheduled to go to trial August 1, 2022. This report shares Optum and Change Healthcare customers’ reactions to the merger and their perceptions of its impact. Between March 2021 and April 2022, KLAS interviewed 48 individuals from 46 unique organizations; of these respondents, 9% are Optum customers, 56% are Change Healthcare customers, and 35% are customers of both vendors.

Company/solution	Overall performance score (100-point scale)	Trend (2020-2021)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Merative IBM Watson Health Merge Hemo	82.3	0%	n=35	B	A-	B	B	C+	C

GE HealthCare GE Healthcare Mac-Lab	79.0	0%	n=24	B-	B	B	B-	B-	C+

Optum Change Healthcare Cardiology Hemo	74.8	0%	n=26	C+	C+	C+	B-	C+	D-

Philips Xper Hemodynamics	74.1	0%	n=19	D+	C+	C+	C+	C	C-
	50.0	100.0

Cardiology Hemodynamics

Past Cardiology Hemodynamics Awards

Contact KLAS

Tell us about your organization

How can we help you?